Cognitive impairment in Parkinson's disease

Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study

(2014) Cristina Nombela et al.   BRAIN

Targeting impulsivity in Parkinson’s disease using atomoxetine

(2014) Angie A. Kehagia et al.   BRAIN

Binding of the PET Radiotracer [18F]BF227 Does not Reflect the Presence of Alpha-Synuclein Aggregates in Transgenic Mice

(2014) Elise Levigoureux et al.   Current Alzheimer Research

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

(2014) H.-F. Wang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Psychiatric issues in cognitive impairment

(2014) Dag Aarsland et al.   MOVEMENT DISORDERS

Mortality in Parkinson's disease: A systematic review and meta-analysis

(2014) Angus D. Macleod et al.   MOVEMENT DISORDERS

Cognitive impairment and dementia in Parkinson's disease: Practical issues and management

(2014) Murat Emre et al.   MOVEMENT DISORDERS

The spectrum of cognitive impairment in Lewy body diseases

(2014) Jennifer G. Goldman et al.   MOVEMENT DISORDERS

The neurobiological basis of cognitive impairment in Parkinson's disease

(2014) Glenda M. Halliday et al.   MOVEMENT DISORDERS

Cortical thinning associated with mild cognitive impairment in Parkinson's disease

(2014) Bàrbara Segura et al.   MOVEMENT DISORDERS

Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease

(2014) Nagaendran Kandiah et al.   PARKINSONISM & RELATED DISORDERS

Cholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activity

(2014) Bernard Bloem et al.   Frontiers in Neural Circuits

Mild cognitive impairment in Parkinson's disease

(2013) A. J. Yarnall et al.   AGE AND AGEING

Cholinergic Dysfunction in Parkinson’s Disease

(2013) Martijn L. T. M. Müller et al.   Current Neurology and Neuroscience Reports

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

(2013) Caroline H Williams-Gray et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prefrontal Cholinergic Mechanisms Instigating Shifts from Monitoring for Cues to Cue-Guided Performance: Converging Electrochemical and fMRI Evidence from Rats and Humans

(2013) W. M. Howe et al.   JOURNAL OF NEUROSCIENCE

Dopamine overdose hypothesis: Evidence and clinical implications

(2013) David E. Vaillancourt et al.   MOVEMENT DISORDERS

Measuring mild cognitive impairment in patients with Parkinson's disease

(2013) Connie Marras et al.   MOVEMENT DISORDERS

Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease?

(2013) Gordon W. Duncan et al.   MOVEMENT DISORDERS

Nonpharmacological enhancement of cognitive function in Parkinson's disease: A systematic review

(2013) John V. Hindle et al.   MOVEMENT DISORDERS

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

(2013) Glenn T. Stebbins et al.   MOVEMENT DISORDERS

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

(2013) David J. Irwin et al.   NATURE REVIEWS NEUROSCIENCE

Evolution of mild cognitive impairment in Parkinson disease

(2013) M. Broeders et al.   NEUROLOGY

Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study

(2013) A. J. Yarnall et al.   NEUROLOGY

Palliative care for Parkinson’s disease: A summary of the evidence and future directions

(2013) Edward W Richfield et al.   PALLIATIVE MEDICINE

Cognitive reserve in Parkinson's disease: A systematic review and meta-analysis

(2013) John V. Hindle et al.   PARKINSONISM & RELATED DISORDERS

Prognosis of Mild Cognitive Impairment in Early Parkinson Disease

(2013) Kenn Freddy Pedersen et al.   JAMA Neurology

Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs WithoutGBAMutations

(2013) Lama M. Chahine et al.   JAMA Neurology

Risk of dementia in an elderly population of Parkinson's disease patients: A 15-year population-based study

(2012) Florian Perez et al.   Alzheimers & Dementia

Neuropathologic substrates of Parkinson disease dementia

(2012) David J. Irwin et al.   ANNALS OF NEUROLOGY

The differing roles of the frontal cortex in fluency tests

(2012) Gail Robinson et al.   BRAIN

Heterogeneity of Cholinergic Denervation in Parkinson's Disease without Dementia

(2012) Nicolaas I Bohnen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Cognitive Impairment in Parkinson Disease

(2012) Iracema Leroi et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients

(2012) Maria Teresa Pellecchia et al.   JOURNAL OF NEUROLOGY

Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease

(2012) Michele Poletti et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients

(2012) Man Auyeung et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment

(2012) Per Svenningsson et al.   LANCET NEUROLOGY

Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study

(2012) Bruno Dubois et al.   MOVEMENT DISORDERS

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis

(2012) Angie A. Kehagia et al.   Neurodegenerative Diseases

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)

(2011) W. G. J. Reid et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical validation of movement disorder society-recommended diagnostic criteria for Parkinson's disease with dementia

(2011) Brandon Barton et al.   MOVEMENT DISORDERS

MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI

(2011) Irene Litvan et al.   MOVEMENT DISORDERS

Parkinson's disease: The quintessential neuropsychiatric disorder

(2011) Daniel Weintraub et al.   MOVEMENT DISORDERS

The interplay of cholinergic function, attention, and falls in Parkinson's disease

(2011) Alison Yarnall et al.   MOVEMENT DISORDERS

Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria

(2011) P. Martinez-Martin et al.   PARKINSONISM & RELATED DISORDERS

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

(2010) Alice S. Chen-Plotkin et al.   ANNALS OF NEUROLOGY

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

(2010) P. A. Kempster et al.   BRAIN

Synergistic Interactions between A , Tau, and  -Synuclein: Acceleration of Neuropathology and Cognitive Decline

(2010) L. K. Clinton et al.   JOURNAL OF NEUROSCIENCE

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

(2010) Angie A Kehagia et al.   LANCET NEUROLOGY

Parkinson's disease dementia can be easily detected in routine clinical practice

(2010) Kathy Dujardin et al.   MOVEMENT DISORDERS

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

(2010) D. Weintraub et al.   NEUROLOGY

Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis

(2010) D. Aarsland et al.   NEUROLOGY

Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease

(2009) Philipp M. Meyer et al.   ARCHIVES OF GENERAL PSYCHIATRY

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

Cognitive function in early Parkinson’s disease: a population-based study

(2009) E. Elgh et al.   EUROPEAN JOURNAL OF NEUROLOGY

Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study

(2009) U. Ehrt et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of Dopaminergic Medications on the Time Course of Explicit Motor Sequence Learning in Parkinson's Disease

(2009) Youngbin Kwak et al.   JOURNAL OF NEUROPHYSIOLOGY

Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance

(2008) Laura Parkkinen et al.   ACTA NEUROPATHOLOGICA

Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype

(2008) J-P Taylor et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS

Lack of association of APOE and tau polymorphisms with dementia in Parkinson’s disease

(2008) Mario Ezquerra et al.   NEUROSCIENCE LETTERS